Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ji Desheng snake tablets are a traditional Chinese medicine (TCM) formulation used primarily for the treatment of venomous snakebites, particularly those from *Agkistrodon halys* (viper) and other venomous species. The formulation was developed by the renowned physician Ji Desheng and is produced by companies like Nantong Jinghua Pharmaceutical. It is designed to detoxify, reduce swelling, and alleviate pain. The tablets contain a complex mixture of herbal and animal-derived ingredients, including Paris polyphylla (Chonglou), Toad venom (Bufonis Venenum), and other traditional components. In clinical settings, it is often used as a standard control or in combination with other therapies for envenomation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ji Desheng snake tablets.